Contact

Professor Andrew Lotery

Consultant Ophthalmologist
MB Bch, MD, FRCOphth

Practising at

Spire Southampton Hospital

Back to top

Treatment information

Some of the principal treatments carried out by Professor Andrew Lotery at Spire include:

Ophthalmology

Back to top

Professional profile

I trained in medicine at Queen's University Belfast and graduated with distinction in 1989. After my general ophthalmology training in Belfast I was awarded an MD for research into the genetics of an inherited form of macular degeneration. Subsequently I completed a two year medical retina sub-specialist fellowship at the University of Iowa, USA. I was then recruited to the retinal faculty at the University of Iowa Hospitals and Clinics where I worked for two years prior to being appointed Professor of Ophthalmology at the University of Southampton. During my four years in the United States I gained experience in the management of macular degeneration, inherited retinal diseases and diabetic retinopathy.

I perform sutureless cataract surgery using topical anaesthesia and treat retinal diseases with cold (PDT) and hot lasers and pioneering new treatments. My research has resulted in the identification of two genes which cause eye disease and the location of a third macular degeneration gene. I have also worked on a gene therapy for eye diseases. My research has been recognised with awards from the Queen's University of Belfast, the University of Iowa and various funding bodies.


Private contact details

Private secretary Jean Vaughan
Private secretary telephone 0845 652 2515
Private secretary email jean.vaughan@nuffieldhealth.com
Back to top

Current NHS posts

Professor of Ophthalmology, University of Southampton

Honorary Consultant Ophthalmic Surgeon, Southampton University Hospitals NHS Trust

Back to top

Personal Profile

I am married with two young children. When time permits I enjoy travel, cycling and hill walking.

Back to top

Financial Interests

Holds less than 0.1% of the shares in Spire Healthcare Group Plc

Back to top